 9-APR-1987 16:52:22.24

SMITHKLINE <SKB> VACCINE GETS APPROVAL OVERSEAS

Smithkline Beckman Corp said its genetically engineered hepatitis B vaccine has received regulatory approval for marketing in Switzerland and Luxembourg.
 The vaccine, called Engerix-B, has been approved in several other countries, including Belgium and Hong Kong.
 Smithkline said it is currently considering marketing avenues in the United States.
 Merck and Co <MRK> also has a genetically engineered vaccine being marketed in several foreign markets, according to industry sources.  Reuter &#3;

